<DOC>
	<DOCNO>NCT00761098</DOCNO>
	<brief_summary>Spontaneous bacterial peritonitis ( SBP ) common frequently fatal complication end-stage liver disease mortality 10 % , primarily due development kidney failure . Current standard practice treat infection broad spectrum antibiotic salt-poor albumin administration day one three treatment . In study investigator test hypothesis administration second dose albumin 48 hour patient renal insufficiency , effective prevent kidney failure administer second dose patient 72 hour .</brief_summary>
	<brief_title>Randomized Comparison Two Albumin Administration Schedules Spontaneous Bacterial Peritonitis ( SBP )</brief_title>
	<detailed_description>Spontaneous bacterial peritonitis ( SBP ) , infection peritoneal fluid ( ascites ) without evidence surgically treatable source , common frequently fatal complication patient endstage hepatic cirrhosis . It originate passage bacteria intestinal lumen systemic circulation ascitic fluid . Early diagnosis paracentesis ( aspiration ascites fluid sample assess evidence infection ) development nonnephrotoxic third generation cephalosporin antibiotic decrease hospital mortality nearly 100 % approximately 30 % . Mortality patient SBP invariably associate development functional renal failure . Recently , administration two large dos human serum albumin diagnosis 72 hour report reduce mortality renal failure 10 % . These finding lead recommendation patient SBP treat albumin . However , study evaluate necessary amount time albumin administration require beneficial action . In study test hypothesis administration second dose albumin 48 hour patient renal insufficiency , effective prevent kidney failure administer second dose patient 72 hour . 80 consecutive patient cirrhosis SBP risk renal failure enrol either Columbia University Medical Center The New York Hospital Weill Cornell Medical Center . Baseline clinical biochemical data obtain etiology severity liver disease . All patient receive antibiotic salt poor albumin 1.5g/kg time diagnosis diuretic discontinue ( current standard care ) . Patients randomize receive second dose ( 1.0 gm/kg ) 72 hour ( group 1 , standard care ) 48 hour renal function remain elevated two day therapy ( Group 2 ) . For latter group patient , albumin administer Cr &gt; 1.0 mg/dl BUN creatinine level high admission level 48 hour . If albumin administer 48 hour , renal function monitor daily , administer BUN creatinine increase level great admission . Renal failure rate , duration transient azotemia , mortality , albumin utilization rat compare group receive albumin usual manner 72 hour versus receive 48 hour base renal function .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<criteria>Age 18 75 End Stage Liver Disease / Cirrhosis Documented SBP ( ANC &gt; 250 positive ascites culture ) Ability provide inform consent Serum Creatinine &gt; 1.0 and/or Total Bilirubin &gt; 4.0 Nonportal hypertensive ascites ( i.e . malignancy ) Hepatic Encephalopathy preclude informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Cirrhosis</keyword>
	<keyword>SBP</keyword>
</DOC>